We have located links that may give you full text access.
Gonioscopy-Assisted Transluminal Trabeculotomy Outcomes under Different Levels of Glaucoma Severity: a Multicenter, Comparative Study.
American Journal of Ophthalmology 2024 March 2
PURPOSE: To evaluate the outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) under different levels of glaucoma severity.
DESIGN: Retrospective, multicenter, before-and-after study.
METHODS: One eye from all POAG patients that underwent both Phaco-GATT or GATT stand-alone with 12 months of follow-up were included and divided according to glaucoma severity (mild - GI; moderate - GII and advanced - GIII) and the outcomes compared.
RESULTS: A total of 270 eyes were included: 90 in GI, 75 in GII and 105 in GIII. The IOP was reduced from 18.6 ± 6.0 mmHg in GI, 19.7 ± 6.4 mmHg in GII and 21.0 ± 7.9 mmHg in GIII, preoperatively, to 11.9 ± 2.6 mmHg in GI, 11.8 ± 2.1 mmHg in GII and 11.9 ± 3.0 mmHg in GIII at 12 months postoperatively (p<0.001 for all). The number of hypotensive ocular medications were reduced from 2.7 ± 1.0 in GI, 3.1 ± 0.8 in GII, and 3.2 ± 1.2 in GIII to 0.6 ± 0.9 in GI, 1.0 ± 1.1 in GII, and 1.2 ± 1.1 in GIII at the last postoperative visit (p<0.001 for all). Relative success was achieved, at one year, in 93.8% of the eyes in GI, 89.0% in GII and 88.1% in GIII (p=0.3). Complete success was achieved in 61.8% of the eyes in GI, 43.8% in GII and 37.6% in GIII (p=0.007). No serious adverse event was observed in any group.
CONCLUSIONS: GATT is a safe and effective procedure in glaucoma, regardless of its preoperative severity.
DESIGN: Retrospective, multicenter, before-and-after study.
METHODS: One eye from all POAG patients that underwent both Phaco-GATT or GATT stand-alone with 12 months of follow-up were included and divided according to glaucoma severity (mild - GI; moderate - GII and advanced - GIII) and the outcomes compared.
RESULTS: A total of 270 eyes were included: 90 in GI, 75 in GII and 105 in GIII. The IOP was reduced from 18.6 ± 6.0 mmHg in GI, 19.7 ± 6.4 mmHg in GII and 21.0 ± 7.9 mmHg in GIII, preoperatively, to 11.9 ± 2.6 mmHg in GI, 11.8 ± 2.1 mmHg in GII and 11.9 ± 3.0 mmHg in GIII at 12 months postoperatively (p<0.001 for all). The number of hypotensive ocular medications were reduced from 2.7 ± 1.0 in GI, 3.1 ± 0.8 in GII, and 3.2 ± 1.2 in GIII to 0.6 ± 0.9 in GI, 1.0 ± 1.1 in GII, and 1.2 ± 1.1 in GIII at the last postoperative visit (p<0.001 for all). Relative success was achieved, at one year, in 93.8% of the eyes in GI, 89.0% in GII and 88.1% in GIII (p=0.3). Complete success was achieved in 61.8% of the eyes in GI, 43.8% in GII and 37.6% in GIII (p=0.007). No serious adverse event was observed in any group.
CONCLUSIONS: GATT is a safe and effective procedure in glaucoma, regardless of its preoperative severity.
Full text links
Related Resources
Trending Papers
Angiotensin Receptor Blocker-Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction.Pharmacological Research : the Official Journal of the Italian Pharmacological Society 2024 May 12
Hemodynamic Support in Sepsis.Anesthesiology 2024 June 2
The Therapy and Management of Heart Failure with Preserved Ejection Fraction: New Insights on Treatment.Cardiac Failure Review 2024
European Respiratory Society Clinical Practice Guideline on symptom management for adults with serious respiratory illness.European Respiratory Journal 2024 May 9
Axillary Surgery for Breast Cancer in 2024.Cancers 2024 April 24
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app